Keyphrases
Acute Lymphoblastic Leukemia
100%
Neurotoxicity
100%
VP16
100%
Intrathecal Drug Delivery
100%
Acute Neurotoxicity
80%
L-asparaginase
60%
Leucovorin
60%
Methotrexate
60%
Continuation Therapy
60%
Toxic Effects
40%
One Dose
40%
Intrathecal
40%
Central Nervous System
20%
Childhood Acute Lymphoblastic Leukemia
20%
Consolidation Therapy
20%
Cytarabine
20%
Daunorubicin
20%
6-mercaptopurine (6-MP)
20%
Two-dose
20%
Seizure
20%
Transient Neurological Deficits
20%
Methotrexate Toxicity
20%
Tion
20%
Oral Dose
20%
Hydrocortisone
20%
Folate
20%
Consolidation Treatment
20%
Methotrexate Treatment
20%
Daily Dose
20%
Prednisone
20%
Ment
20%
Intrathecal Methotrexate
20%
Divided Dose
20%
Consolida
20%
Oral Methotrexate
20%
Duction
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Intrathecal
100%
Methotrexate
87%
Neurotoxicity
50%
Asparaginase
37%
Folinic Acid
37%
Toxicity
25%
Malignant Neoplasm
12%
Vincristine
12%
Daunorubicin
12%
Cytarabine
12%
Hydrocortisone
12%
Prednisone
12%
Mercaptopurine
12%
Lanoteplase
12%
Elimination
12%
Folic Acid
12%
Neuroscience
Intrathecal
100%
Methotrexate
87%
Neurotoxicity
50%
Asparaginase
37%
Folinic Acid
37%
Central Nervous System
12%
Prednisone
12%
Cytarabine
12%
Folate
12%
Vincristine
12%
Folic Acid
12%
Lanoteplase
12%
Daunorubicin
12%
Cortisol
12%
Mercaptopurine
12%